Developing Novel Biointerfaces: Using Chlorhexidine Surface Attachment as a Method for Creating Anti-Fungal Surfaces

Area of Science:

• Medical Microbiology
• Materials Science
• Infectious Disease Control

Background:

• Antimicrobial resistance is a growing global health threat, with fungal infections often overlooked despite their severity.
• Fungal pathogens pose significant risks in healthcare environments, necessitating advanced control strategies.
• Existing technologies for combating fungal infections are limited due to shared human-fungal biology and inadequate hospital infrastructure.

Purpose of the Study:

• To develop and evaluate a novel antimicrobial surface (AMS) for combating opportunistic fungal pathogens.
• To assess the efficacy of chlorhexidine-modified surfaces against key fungal species.
• To compare the performance of the novel AMS with existing antimicrobial technologies.

Main Methods:

• Modification of surfaces with the broad-spectrum biocide chlorhexidine.
• Testing the antimicrobial activity of the modified surfaces against Candida albicans and Cryptococcus neoformans.
• Comparative analysis of the novel AMS efficacy against commercial antimicrobial surfaces like silver and copper.

Main Results:

• The novel antimicrobial surface demonstrated rapid killing of Candida albicans and Cryptococcus neoformans within 15 minutes.
• The chlorhexidine-modified surfaces showed significantly higher efficacy compared to current market technologies.
• The AMS proved effective against opportunistic fungal pathogens, addressing a critical gap in infection control.

Conclusions:

• Novel chlorhexidine-modified antimicrobial surfaces offer a promising solution for controlling deadly fungal infections.
• This technology presents a significant advancement over existing antimicrobial surfaces for healthcare applications.
• The development of effective strategies against fungal antimicrobial resistance is crucial for public health.